San Diego Blood Donors Get Free Genome Sequencing
By David Wagner,
KPBS
| 11. 24. 2015
Untitled Document
A select group of blood donors at this year's Chargers Blood Drive gave one extra tube of blood. That's because they're not just donating blood — they're also getting their genome sequenced.
San Diego-based Illumina is providing free sequencing to 70 San Diego Blood Bank donors. The Blood Bank's goal is to compile a DNA database for researchers to comb through in hopes of pinpointing genes linked with health outcomes.
La Mesa resident Penelope Navarro was one of the pre-selected participants. She signed up to learn about the diseases her family may need to look out for.
"I'm a breast cancer survivor," Navarro said. "And I have children and grandchildren. So I thought an experience like this would help in perhaps finding out whether or not that's something they might need to be looking into as they grow older."
By participating, Navarro agreed to provide her DNA for research purposes, letting scientists search her genes for correlations with diseases like breast cancer. She'll also be able to access her genome online and learn more about it at an...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
